Enifer secures €36M in Series B funding to build food-grade mycoprotein factory in Finland

May 23, 2024•about 1 year ago

Amount Raised

€36 Million

Round Type

series b

EspooBiotechnology Research

Investors

FinnveraFinnish Climate FundValioVoima VenturesNordic Foodtech VcTaaleri Bioindustry Fund I

Description

Enifer has secured a €36 million funding package, including a new €15 million Series B equity funding round led by the Finnish private equity fund Taaleri Bioindustry Fund I, with follow-on investments from existing shareholders Nordic Foodtech VC, Voima Ventures, and Valio. The funding also includes a €7 million junior loan from the Finnish Climate Fund and a €2 million Climate and Environmental Loan from Finnvera.

Company Information

Company

Enifer

Location

Espoo, Etelä-Suomi, Finland

About

We work to create a better future utilizing fewer natural resources. Sustainably produced protein is one of the most important aims for the future food production and the very issue we're going to tackle. A spin-off from the VTT Technical Research Centre of Finland, Enifer is at the forefront of developing the next-generation food system. Our focus is perfecting the production process for PEKILO® mycoprotein, a form of single-cell protein derived from fungi. Uniquely, our process has seen more than 15 years of industrial scale operation and is the most efficient alternative protein process out there. Sustainable protein ready to scale!

Related People

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends